Biernat, M.M.; Kolasińska, A.; Kwiatkowski, J.; Urbaniak-Kujda, D.; Biernat, P.; Janocha-Litwin, J.; Szymczyk-Nużka, M.; Bursy, D.; Kalicińska, E.; Simon, K.;
et al. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses 2021, 13, 436.
https://doi.org/10.3390/v13030436
AMA Style
Biernat MM, Kolasińska A, Kwiatkowski J, Urbaniak-Kujda D, Biernat P, Janocha-Litwin J, Szymczyk-Nużka M, Bursy D, Kalicińska E, Simon K,
et al. Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses. 2021; 13(3):436.
https://doi.org/10.3390/v13030436
Chicago/Turabian Style
Biernat, Monika Maria, Anna Kolasińska, Jacek Kwiatkowski, Donata Urbaniak-Kujda, Paweł Biernat, Justyna Janocha-Litwin, Małgorzata Szymczyk-Nużka, Dawid Bursy, Elżbieta Kalicińska, Krzysztof Simon,
and et al. 2021. "Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19" Viruses 13, no. 3: 436.
https://doi.org/10.3390/v13030436
APA Style
Biernat, M. M., Kolasińska, A., Kwiatkowski, J., Urbaniak-Kujda, D., Biernat, P., Janocha-Litwin, J., Szymczyk-Nużka, M., Bursy, D., Kalicińska, E., Simon, K., Mazur, G., & Wróbel, T.
(2021). Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19. Viruses, 13(3), 436.
https://doi.org/10.3390/v13030436